Valence-Logo
Beliebt
Anmelden
Loading data for CANC — first visit, this takes a few seconds.

Zur Watchlist hinzufügen

Tema Oncology ETF

NasdaqGM: CANC · Echtzeitkurs · USD
44.05
+0.31 (0.71%)
Zum Schluss: Aug 20, 2026, 7:58 PM
44.05
+0.00%
Nachbörslich: 4:04 PM

Tema Oncology ETF (CANC) Stock Price, Analysis & Data

0.71%

Keine Daten verfügbar

Geld41.61
Marktkapitalisierungn/a
Umsatz (TTM)n/a
Nettogewinn (TTM)n/a
Betan/a
EPS (ttm)n/a
KGV (TTM)27.71
Forward-KGVn/a
KBV (TTM)n/a
KUV (TTM)n/a
Earnings Daten/a
Brief42.11
Volumen64,506
Ø Vol. (20D)33,098
Eröffnung44.84
Vortagesschluss43.74
Tagesspanne44.52 - 45.35
52-Wk Range26.24 - 45.35
Analystn/a
Kurszieln/a
Dividendenn/a
Ex-Dividenden-Datumn/a

Über CANC

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified....

[Mehr lesen]
Branche n/a
Sektor n/a
IPO Datum Aug 14, 2023
Mitarbeiter n/a
Börse NasdaqGM
Tickersymbol CANC
Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr undefined betrug der Umsatz von Tema Oncology ETF n/a, ein Anstieg von undefined% im Vergleich zum Vorjahr (n/a). Der Gewinn lag bei n/a, ein Anstieg von undefined %.

Finanzberichte
news image

vor 7 Monaten · Zacks

Here's Why Biotech ETFs Are Rallying Hard

Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.

news image

vor 8 Monaten · Zacks

Be Thankful to These ETFs This Year

Be thankful for this year's resilient ETFs -- BWET, LITP, PINK and CANC -- which shined despite volatility, tariffs, AI worries and Fed shifts.

news image

vor 9 Monaten · Zacks

Inside the Recent Strength in Biotech ETFs

Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.